Home

Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsorsort icon State
2009-07-03 Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). CIMAB Registered
2009-07-03 Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. CIMAB Registered outdated
2009-07-03 Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. CIMAB Registered
2009-07-03 Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. CIMAB Registered
2009-07-10 Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. CIMAB Registered
2009-07-24 Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. CIMAB Registered
2009-07-24 Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. CIMAB Registered
2009-08-20 Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. CIMAB Registered
2009-09-18 Effectiveness and Safety of Nimotuzumab for the treatment of patients with glioma tumors CIMAB Registered
2009-10-22 Effectiveness and safety of ior EPOCIM in anemia in premature infant. CIMAB Registered
2009-10-22 Nimotuzumab- Head and neck cancer CIMAB Registered
2009-10-23 EPOCIM in benign prostatic hyperplasia. CIMAB Registered
2010-06-11 Effect and Safety of ior® EPOCIM in patients with Non-Hodking Lymphoma treated with anthracyclines. CIMAB Registered
2013-06-10 NeuroEPO in healthy volunteers. CIMAB Registered
14/08/2014 Study of intensive pediatric pharmacovigilance of nimotuzumab for the treatment of malignant glioma tumors. CIMAB Registered
26/08/2013 ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease. CIMAB Registered outdated
11/09/2014 NeuroEPO-Stroke. Phase I-II CIMAB Registered
02/11/2014 NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II CIMAB Registered
02/11/2021 Moringa in Diabetes CIPPPB Registered outdated
2009-05-29 rTMS-stroke-phase I CIREN Registered